{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,22]],"date-time":"2026-07-22T23:52:38Z","timestamp":1784764358436,"version":"3.55.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","pathologyjournal.rcpa.edu.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Pathology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/j.pathol.2022.01.009","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T07:00:31Z","timestamp":1651734031000},"page":"686-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis"],"prefix":"10.1016","volume":"54","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0436-033X","authenticated-orcid":false,"given":"Sadhna","family":"Dhingra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juhi D.","family":"Mahadik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yaman","family":"Tarabishy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1489-8053","authenticated-orcid":false,"given":"Sarah B.","family":"May","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5547-6020","authenticated-orcid":false,"given":"John M.","family":"Vierling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pathol.2022.01.009_bib1","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/hep.29721","article-title":"Diagnostic modalities for nonalcoholic fatty liver disease, nonalcoholic steatohepatitis, and associated fibrosis","volume":"68","author":"Younossi","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib2","doi-asserted-by":"crossref","first-page":"1874","DOI":"10.1002\/hep.24268","article-title":"Pathologic criteria for nonalcoholic steatohepatitis: interprotocol agreement and ability to predict liver-related mortality","volume":"53","author":"Younossi","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib3","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1053\/j.gastro.2010.09.038","article-title":"Prevalence of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among a largely middle-aged population utilizing ultrasound and liver biopsy: a prospective study","volume":"140","author":"Williams","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2022.01.009_bib4","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.clinthera.2021.07.012","article-title":"Current and emerging biomarkers and imaging modalities for nonalcoholic fatty liver disease: clinical and research applications","volume":"43","author":"Hydes","year":"2021","journal-title":"Clin Ther"},{"key":"10.1016\/j.pathol.2022.01.009_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.4254\/wjh.v10.i8.530","article-title":"Current status of imaging in nonalcoholic fatty liver disease","volume":"10","author":"Li","year":"2018","journal-title":"World J Hepatol"},{"issue":"Suppl 1","key":"10.1016\/j.pathol.2022.01.009_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/liv.13653","article-title":"Diagnosis of non-alcoholic fatty liver disease\/non-alcoholic steatohepatitis: why liver biopsy is essential","volume":"38","author":"Bedossa","year":"2018","journal-title":"Liver Int"},{"key":"10.1016\/j.pathol.2022.01.009_bib7","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1002\/hep.31599","article-title":"Nonalcoholic fatty liver disease: reporting histologic findings in clinical practice","volume":"73","author":"Brunt","year":"2020","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib8","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","article-title":"Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity","volume":"116","author":"Matteoni","year":"1999","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2022.01.009_bib9","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1097\/01.MP.0000042420.21088.C7","article-title":"Concurrence of histologic features of steatohepatitis with other forms of chronic liver disease","volume":"16","author":"Brunt","year":"2003","journal-title":"Mod Pathol"},{"key":"10.1016\/j.pathol.2022.01.009_bib10","series-title":"CymaBay Therapeutics halts clinical development of seladelpar","year":"2019"},{"key":"10.1016\/j.pathol.2022.01.009_bib11","series-title":"CymaBay reports first quarter 2020 financial results and provides corporate update","year":"2020"},{"key":"10.1016\/j.pathol.2022.01.009_bib12","series-title":"FDA lifts all clinical holds on seladelpar","year":"2020"},{"key":"10.1016\/j.pathol.2022.01.009_bib13","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1002\/hep.20701","article-title":"Design and validation of a histological scoring system for nonalcoholic fatty liver disease","volume":"41","author":"Kleiner","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib14","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1016\/0168-8278(95)80226-6","article-title":"Histological grading and staging of chronic hepatitis","volume":"22","author":"Ishak","year":"1995","journal-title":"J\u00a0Hepatol"},{"key":"10.1016\/j.pathol.2022.01.009_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1002\/lt.21447","article-title":"Posttransplant plasma cell hepatitis (de novo autoimmune hepatitis) is a variant of rejection and may lead to a negative outcome in patients with hepatitis C virus","volume":"14","author":"Fiel","year":"2008","journal-title":"Liver Transpl"},{"key":"10.1016\/j.pathol.2022.01.009_bib16","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/hep.510280206","article-title":"The normal adult human liver biopsy: a quantitative reference standard","volume":"28","author":"Crawford","year":"1998","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1002\/hep.26937","article-title":"The portal inflammatory infiltrate and ductular reaction in human nonalcoholic fatty liver disease","volume":"59","author":"Gadd","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib18","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1111\/j.1572-0241.1999.01377.x","article-title":"Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions","volume":"94","author":"Brunt","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/j.pathol.2022.01.009_bib19","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1002\/hep.22724","article-title":"Portal chronic inflammation in nonalcoholic fatty liver disease (NAFLD): a histologic marker of advanced NAFLD-clinicopathologic correlations from the Nonalcoholic Steatohepatitis Clinical Research Network","volume":"49","author":"Brunt","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib20","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.1381\/096089206779319392","article-title":"Hepatic histopathology of morbid obesity: concurrence of other forms of chronic liver disease","volume":"16","author":"Liew","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/j.pathol.2022.01.009_bib21","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1136\/jcp.2010.079145","article-title":"Portal inflammation is associated with advanced histological changes in alcoholic and non-alcoholic fatty liver disease","volume":"63","author":"Rakha","year":"2010","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2022.01.009_bib22","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1007\/s10620-016-4062-0","article-title":"Histological assessment of NAFLD","volume":"61","author":"Bedossa","year":"2016","journal-title":"Dig Dis Sci"},{"key":"10.1016\/j.pathol.2022.01.009_bib23","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.12565","article-title":"Association of histologic disease activity with progression of nonalcoholic fatty liver disease","volume":"2","author":"Kleiner","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.pathol.2022.01.009_bib24","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1002\/hep.30418","article-title":"Improvements in histologic features and diagnosis associated with improvement in fibrosis in nonalcoholic steatohepatitis: results from the Nonalcoholic Steatohepatitis Clinical Research Network treatment trials","volume":"70","author":"Brunt","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib25","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1038\/nri1412","article-title":"Fibrotic disease and the T(H)1\/T(H)2 paradigm","volume":"4","author":"Wynn","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/j.pathol.2022.01.009_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.3389\/fimmu.2020.01142","article-title":"Cells in fibrosis and fibrotic diseases","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/j.pathol.2022.01.009_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1016\/j.jaci.2019.07.004","article-title":"B\u00a0lymphocytes directly contribute to tissue fibrosis in patients with IgG(4)-related disease","volume":"145","author":"Della-Torre","year":"2020","journal-title":"J\u00a0Allergy Clin Immunol"},{"key":"10.1016\/j.pathol.2022.01.009_bib28","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1053\/j.gastro.2007.05.012","article-title":"Progressive fibrosis in nonalcoholic steatohepatitis: association with altered regeneration and a ductular reaction","volume":"133","author":"Richardson","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2022.01.009_bib29","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1053\/j.gastro.2013.11.034","article-title":"Links between hepatic fibrosis, ductular reaction, and progenitor cell expansion","volume":"146","author":"Williams","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/j.pathol.2022.01.009_bib30","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1034\/j.1600-0676.2002.01623.x","article-title":"Progression of fibrosis in untreated patients with hepatitis C virus infection","volume":"22","author":"Lagging","year":"2002","journal-title":"Liver"},{"key":"10.1016\/j.pathol.2022.01.009_bib31","doi-asserted-by":"crossref","first-page":"11033","DOI":"10.3748\/wjg.v20.i32.11033","article-title":"Chronic hepatitis C and liver fibrosis","volume":"20","author":"Sebastiani","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/j.pathol.2022.01.009_bib32","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/jcp.2011.090175","article-title":"Participation of bile ductular cells in the pathological progression of non-alcoholic fatty liver disease","volume":"64","author":"Chiba","year":"2011","journal-title":"J\u00a0Clin Pathol"},{"key":"10.1016\/j.pathol.2022.01.009_bib33","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1002\/hep.27175","article-title":"Saturated free fatty acids induce cholangiocyte lipoapoptosis","volume":"60","author":"Natarajan","year":"2014","journal-title":"Hepatology"},{"key":"10.1016\/j.pathol.2022.01.009_bib34","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1194\/jlr.M071357","article-title":"FoxO3 increases miR-34a to cause palmitate-induced cholangiocyte lipoapoptosis","volume":"58","author":"Natarajan","year":"2017","journal-title":"J\u00a0Lipid Res"}],"container-title":["Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522001234?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0031302522001234?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,11,21]],"date-time":"2023-11-21T02:17:38Z","timestamp":1700533058000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0031302522001234"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S0031302522001234"],"URL":"https:\/\/doi.org\/10.1016\/j.pathol.2022.01.009","relation":{},"ISSN":["0031-3025"],"issn-type":[{"value":"0031-3025","type":"print"}],"subject":[],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence and clinical significance of portal inflammation, portal plasma cells, interface hepatitis and biliary injury in liver biopsies from patients with non-alcoholic steatohepatitis","name":"articletitle","label":"Article Title"},{"value":"Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pathol.2022.01.009","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Royal College of Pathologists of Australasia. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}